Seres Therapeutics, Inc. (MCRB): 8-K filed Nov 4, 2026

Form type

8-K

Filing date

Nov 4, 2026

Accession number

0001193125-26-446185

Filer

Seres Therapeutics, Inc. (CIK 1609809)